Bio Medica Lab

Why is Bio Medica Lab falling/rising?

As of 10-Jun, Bio Medica Laboratories Ltd's stock price is at 124.80, down 4.11% due to underperformance relative to its sector and a significant drop in investor participation. Despite trading above its moving averages, negative market sentiment and reduced trading volume are driving the decline.

As of 10-Jun, Bio Medica Laboratories Ltd's stock price is currently at 124.80, reflecting a decline of 5.35, or 4.11%. This decrease can be attributed to several factors. Firstly, the stock has underperformed its sector by 3.65% today, indicating weaker performance relative to its peers. Additionally, there has been a notable drop in investor participation, with the delivery volume on June 9 falling by 67.6% compared to the 5-day average, suggesting reduced interest from investors. <BR><BR>Despite the stock trading higher than its moving averages across various time frames (5-day, 20-day, 50-day, 100-day, and 200-day), the overall market sentiment appears negative, as evidenced by the stock's performance today and the decline in trading volume. These factors combined contribute to the current downward movement in the stock price.

What does Bio Medica Lab do?

Bio Medica Laboratories Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology sector, incorporated in 2015. It has a market cap of INR 167 Cr, with a P/E ratio of 16.00 and a return on equity of 66.45%.

Overview: <BR>Bio Medica Laboratories Ltd operates in the Pharmaceuticals & Biotechnology industry and is classified as a Micro Cap company.<BR><BR>History: <BR>Bio Medica Laboratories Limited was originally incorporated as a private limited company under the name "Bio Medica Laboratories Private Limited" on August 14, 2015, by the Registrar of Companies in Gwalior. There are no recent updates regarding sales and profit data.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 167 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 16.00 <BR>Industry P/E: 34 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 1.02 <BR>Return on Equity: 66.45% <BR>Price-to-Book: 11.17 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Which are the latest news on Bio Medica Lab?

How big is Bio Medica Lab?

As of 10th June, Bio Medica Laboratories Ltd has a market capitalization of 167.00 Cr, classifying it as a Micro Cap company. There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.

As of 10th June, <BR><BR>Market Cap: Bio Medica Laboratories Ltd has a market capitalization of 167.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 14.73 Cr and Total Assets valued at 38.90 Cr.